SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Héctor Arreola Ornelas, Alfonso Rosado Buzzo, Lourdes García, Javier Dorantes Aguilar, Iris Contreras Hernández, Joaquín F. Mould Quevedo, Análisis de coste-efectividad en el tratamiento farmacológico del síndrome de fibromialgia en México, Reumatología Clínica, 2012,

    CrossRef

  2. 2
    Héctor Arreola Ornelas, Alfonso Rosado Buzzo, Lourdes García, Javier Dorantes Aguilar, Iris Contreras Hernández, Joaquín F. Mould Quevedo, Cost-effectiveness Analysis of Pharmacologic Treatment of Fibromyalgia in Mexico, Reumatología Clínica (English Edition), 2012,

    CrossRef

  3. 3
    Robert Bennett, I. Jon Russell, Ernest Choy, Michael Spaeth, Philip Mease, Daniel Kajdasz, Daniel Walker, Fujun Wang, Amy Chappell, Evaluation of Patient-Rated Stiffness Associated With Fibromyalgia: A Post-Hoc Analysis of 4 Pooled, Randomized Clinical Trials of Duloxetine, Clinical Therapeutics, 2012, 34, 4, 824

    CrossRef

  4. 4
    S. L. Whittle, A. N. Colebatch, R. Buchbinder, C. J. Edwards, K. Adams, M. Englbrecht, G. Hazlewood, J. L. Marks, H. Radner, S. Ramiro, B. L. Richards, I. H. Tarner, D. Aletaha, C. Bombardier, R. B. Landewe, U. Muller-Ladner, J. W. J. Bijlsma, J. C. Branco, V. P. Bykerk, G. da Rocha Castelar Pinheiro, A. I. Catrina, P. Hannonen, P. Kiely, B. Leeb, E. Lie, P. Martinez-Osuna, C. Montecucco, M. Ostergaard, R. Westhovens, J. Zochling, D. van der Heijde, Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative, Rheumatology, 2012,

    CrossRef

  5. 5
    Adam Lloyd, Chad S. Boomershine, Ernest H. Choy, Arthi Chandran, Gergana Zlateva, The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective, Journal of Medical Economics, 2012, 15, 3, 481

    CrossRef

  6. 6
    Kim E. Innes, Terry Kit Selfe, The Effects of a Gentle Yoga Program on Sleep, Mood, and Blood Pressure in Older Women with Restless Legs Syndrome (RLS): A Preliminary Randomized Controlled Trial, Evidence-Based Complementary and Alternative Medicine, 2012, 2012, 1

    CrossRef

  7. 7
    Richard B. Berry, Fundamentals of Sleep Medicine, 2012,

    CrossRef

  8. 8
    Douglas Comeau, Kevin Heaton, Andrea Gordon, Textbook of Family Medicine, 2012,

    CrossRef

  9. 9
    Neil S. Roskell, Stephen M. Beard, Yang Zhao, Trong Kim Le, A Meta-Analysis of Pain Response in the Treatment of Fibromyalgia, Pain Practice, 2011, 11, 6
  10. 10
    Ernest Choy, David Marshall, Zahava L. Gabriel, Stephen A. Mitchell, Elizabeth Gylee, Helen A. Dakin, A Systematic Review and Mixed Treatment Comparison of the Efficacy of Pharmacological Treatments for Fibromyalgia, Seminars in Arthritis and Rheumatism, 2011, 41, 3, 335

    CrossRef

  11. 11
    Eric S Hsu, Acute and Chronic Pain Management in Fibromyalgia: Updates on Pharmacotherapy, American Journal of Therapeutics, 2011, 18, 6, 487

    CrossRef

  12. 12
    Danielle L. Petersel, Vardit Dror, Raymond Cheung, Central amplification and fibromyalgia: Disorder of pain processing, Journal of Neuroscience Research, 2011, 89, 1
  13. 13
    Chad M. Brummett, Daniel J. Clauw, Fibromyalgia, Current Opinion in Anaesthesiology, 2011, 24, 5, 532

    CrossRef

  14. 14
    Michael Spaeth, Maurizio Rizzi, Piercarlo Sarzi-Puttini, Fibromyalgia and Sleep, Best Practice & Research Clinical Rheumatology, 2011, 25, 2, 227

    CrossRef

  15. 15
    Deven Karvelas, Sridhar V Vasudevan, Fibromyalgia syndrome, Pain Management, 2011, 1, 6, 557

    CrossRef

  16. 16
    M. Späth, Fibromyalgie, Zeitschrift für Rheumatologie, 2011, 70, 7, 573

    CrossRef

  17. 17
    Pascale Vergne-Salle, Othmane Mejjad, Rose-Marie Javier, Emmanuel Maheu, Michèle Fallut, Jacques Glowinski, Philippe Bertin, Les antiépileptiques dans le traitement des affections douloureuses rhumatologiques. Recommandations établies à partir d’une revue de la littérature basée sur des preuves et l’opinion d’experts, Douleurs : Evaluation - Diagnostic - Traitement, 2011, 12, 5, 249

    CrossRef

  18. 18
    Randolph W. Evans, Marina de Tommaso, Migraine and Fibromyalgia, Headache: The Journal of Head and Face Pain, 2011, 51, 2
  19. 19
    Elana M. Oberstein, Maria Carpintero, Aviva Hopkins, Neck Pain from a Rheumatologic Perspective, Physical Medicine and Rehabilitation Clinics of North America, 2011, 22, 3, 485

    CrossRef

  20. 20
    Anoop Kuttikat, Nicholas Shenker, Pharmacological modulation of central nociception in the management of chronic musculoskeletal pain, Pain Management, 2011, 1, 6, 549

    CrossRef

  21. 21
    Philip J. Mease, Kelly Dundon, Piercarlo Sarzi-Puttini, Pharmacotherapy of fibromyalgia, Best Practice & Research Clinical Rheumatology, 2011, 25, 2, 285

    CrossRef

  22. 22
    Sang-Hyon Kim, Sung-Won Jung, Psychiatric Approach of Fibromyalgia, Journal of Rheumatic Diseases, 2011, 18, 4, 242

    CrossRef

  23. 23
    Gudrun Lange, Malvin N. Janal, Allen Maniker, Jennifer FitzGibbons, Malusha Fobler, Dane Cook, Benjamin H. Natelson, Safety and Efficacy of Vagus Nerve Stimulation in Fibromyalgia: A Phase I/II Proof of Concept Trial, Pain Medicine, 2011, 12, 9
  24. 24
    Anne Chamberlin Siler, Hallie Gardner, Keenan Yanit, Tera Cushman, Marian McDonagh, Systematic Review of the Comparative Effectiveness of Antiepileptic Drugs for Fibromyalgia, The Journal of Pain, 2011, 12, 4, 407

    CrossRef

  25. 25
    Gene-Siew NGIAN, Emma K. GUYMER, Geoffrey O. LITTLEJOHN, The use of opioids in fibromyalgia, International Journal of Rheumatic Diseases, 2011, 14, 1
  26. 26
    Javier Rivera Redondo, Tratamiento farmacológico en la fibromialgia, Seminarios de la Fundación Española de Reumatología, 2011, 12, 1, 21

    CrossRef

  27. 27
    &NA;, Treat the symptoms of fibromyalgia with a variety of strategies, as individual therapies provide only moderate benefits, Drugs & Therapy Perspectives, 2011, 27, 1, 17

    CrossRef

  28. 28
    Paula K. Schweitzer, Principles and Practice of Sleep Medicine, 2011,

    CrossRef

  29. 29
    Howard S. Smith, Richard E. Harris, Daniel J. Clauw, Essentials of Pain Medicine, 2011,

    CrossRef

  30. 30
    Ernest Choy, Selwyn Richards, Kevin Bowrin, Penny Watson, Adam Lloyd, Alesia Sadosky, Gergana Zlateva, Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective, Current Medical Research and Opinion, 2010, 26, 4, 965

    CrossRef

  31. 31
    Don L. Goldenberg, Daniel J. Clauw, Robert H. Palmer, Philip Mease, Wei Chen, R. Michael Gendreau, Durability of Therapeutic Response to Milnacipran Treatment for Fibromyalgia. Results of a Randomized, Double-Blind, Monotherapy 6-Month Extension Study, Pain Medicine, 2010, 11, 2
  32. 32
    T. G. Tzellos, K. A. Toulis, D. G. Goulis, G. Papazisis, V. A. Zampeli, A. Vakfari, D. Kouvelas, Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis, Journal of Clinical Pharmacy and Therapeutics, 2010, 35, 6
  33. 33
    Piercarlo Sarzi-Puttini, Fabiola Atzeni, Marco Cazzola, Neuroendocrine therapy of fibromyalgia syndrome: an update, Annals of the New York Academy of Sciences, 2010, 1193, 1
  34. 34
    Daniel J. Clauw, Perspectives on Fatigue from the Study of Chronic Fatigue Syndrome and Related Conditions, PM&R, 2010, 2, 5, 414

    CrossRef

  35. 35
    Roland Staud, Pharmacological Treatment of Fibromyalgia Syndrome, Drugs, 2010, 70, 1, 1

    CrossRef

  36. 36
    Eduardo S. Paiva, Kim Dupree Jones, Rational treatment of fibromyalgia for a solo practitioner, Best Practice & Research Clinical Rheumatology, 2010, 24, 3, 341

    CrossRef

  37. 37
    Fong-Chi Cheng, Jin-Jye Feng, Kuo-Hsin Chen, Hideyo Imanishi, Masaki Fujishima, Hideo Takekoshi, Yo Naoki, Minoru Shimoda, Receptor binding activities of Chlorella on cysteinyl leukotriene CysLT, glutamate AMPA, ion channels, purinergic P2Y, tachykinin NK2 receptors and adenosine transporter, Phytotherapy Research, 2010, 24, 1
  38. 38
    Michael C. Hsu, Howard Schubiner, Mark A. Lumley, John S. Stracks, Daniel J. Clauw, David A. Williams, Sustained Pain Reduction Through Affective Self-awareness in Fibromyalgia: A Randomized Controlled Trial, Journal of General Internal Medicine, 2010, 25, 10, 1064

    CrossRef

  39. 39
    Don L. Goldenberg, The Interface of Pain and Mood Disturbances in the Rheumatic Diseases, Seminars in Arthritis and Rheumatism, 2010, 40, 1, 15

    CrossRef

  40. 40
    Lesley M. Arnold, The Pathophysiology, Diagnosis and Treatment of Fibromyalgia, Psychiatric Clinics of North America, 2010, 33, 2, 375

    CrossRef

  41. 41
    Leslie J. Crofford, Targeted Treatment of the Rheumatic Diseases, 2010,

    CrossRef

  42. 42
    Vaughn W McCall, Insomnia, 2010,

    CrossRef

  43. 43
    Gaetano Zaccara, Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions, 2010,

    CrossRef

  44. 44
    Chad S. Boomershine, Leslie J. Crofford, A symptom-based approach to pharmacologic management of fibromyalgia, Nature Reviews Rheumatology, 2009, 5, 4, 191

    CrossRef

  45. 45
    Patrick Sichère, Actualisation des thérapeutiques médicamenteuses dans le syndrome fibromyalgique, Douleurs : Evaluation - Diagnostic - Traitement, 2009, 10, 2, 84

    CrossRef

  46. 46
    Françoise Laroche, Actualités de la fibromyalgie, Revue du Rhumatisme, 2009, 76, 6, 529

    CrossRef

  47. 47
    Cristina Viana Zulaica, Antonio Díaz Sánchez, Actualización en el tratamiento de la fibromialgia, FMC - Formación Médica Continuada en Atención Primaria, 2009, 16, 4, 242

    CrossRef

  48. 48
    Eva Kosek, Advances in fibromyalgia treatment: understanding endogenous pain modulation, International Journal of Clinical Rheumatology, 2009, 4, 5, 493

    CrossRef

  49. 49
    Avi Leader, Daniella Amital, Alan Rubinow, Howard Amital, An Open-label Study Adding Creatine Monohydrate to Ongoing Medical Regimens in Patients with the Fibromyalgia Syndrome, Annals of the New York Academy of Sciences, 2009, 1173, 1
  50. 50
    Pascale Vergne-Salle, Othmane Mejjad, Rose Marie Javier, Emmanuel Maheu, Michèle Fallut, Jacques Glowinski, Philippe Bertin, Antiepileptic drugs to treat pain in rheumatic conditions. Recommendations based on evidence-based review of the literature and expert opinion, Joint Bone Spine, 2009, 76, 1, 75

    CrossRef

  51. 51
    J.P. Haas, Chronische muskuloskelettale Schmerzen bei Kindern und Jugendlichen, Monatsschrift Kinderheilkunde, 2009, 157, 7, 647

    CrossRef

  52. 52
    Mugdha Gore, Alesia Beth Sadosky, Gergana Zlateva, Daniel J. Clauw, Clinical Characteristics, Pharmacotherapy and Healthcare Resource Use among Patients with Fibromyalgia Newly Prescribed Gabapentin or Pregabalin, Pain Practice, 2009, 9, 5
  53. 53
    Jill M. Recla, Constantine D. Sarantopoulos, Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: A novel analgesic and neuroprotective strategy?, Medical Hypotheses, 2009, 73, 2, 177

    CrossRef

  54. 54
    Lars Arendt-Nielsen, David Yarnitsky, Experimental and Clinical Applications of Quantitative Sensory Testing Applied to Skin, Muscles and Viscera, The Journal of Pain, 2009, 10, 6, 556

    CrossRef

  55. 55
    Kim D. Jones, Fay B. Horak, Kerri Winters-Stone, Jessica Morea Irvine, Robert M. Bennett, Fibromyalgia Is Associated With Impaired Balance and Falls, JCR: Journal of Clinical Rheumatology, 2009, 15, 1, 16

    CrossRef

  56. 56
    Seong-Ho Kim, Fibromyalgia Syndrome, The Journal of the Korean Rheumatism Association, 2009, 16, 1, 1

    CrossRef

  57. 57
    Emma Guymer, Geoffrey Littlejohn, Fibromyalgia: current diagnosis and management, Expert Review of Clinical Immunology, 2009, 5, 2, 181

    CrossRef

  58. 58
    Dawn A. Marcus, Fibromyalgia: Diagnosis and treatment options, Gender Medicine, 2009, 6, 139

    CrossRef

  59. 59
    Kobby Ablin, Daniel J. Clauw, From Fibrositis to Functional Somatic Syndromes to a Bell-Shaped Curve of Pain and Sensory Sensitivity: Evolution of a Clinical Construct, Rheumatic Disease Clinics of North America, 2009, 35, 2, 233

    CrossRef

  60. 60
    Sangsu Bang, Sungjae Yoo, Sun Wook Hwang, Gabapentin Attenuates the Activation of Transient Receptor Potential A1 by Cinnamaldehyde, Experimental Neurobiology, 2009, 18, 1, 1

    CrossRef

  61. 61
    Konstantinos A. Toulis, Thrasivoulos Tzellos, Dimitrios Kouvelas, Dimitrios G. Goulis, Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: A systematic review and meta-analysis, Clinical Therapeutics, 2009, 31, 2, 221

    CrossRef

  62. 62
    Pascale Vergne-Salle, Othmane Mejjad, Rose-Marie Javier, Emmanuel Maheu, Michèle Fallut, Jacques Glowinski, Philippe Bertin, Les antiépileptiques dans le traitement des affections douloureuses rhumatologiques. Recommandations établies à partir d’une revue de la littérature basée sur des preuves et l’opinion d’experts, Revue du Rhumatisme, 2009, 76, 1, 79

    CrossRef

  63. 63
    Kurt Kroenke, Erin E. Krebs, Matthew J. Bair, Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews, General Hospital Psychiatry, 2009, 31, 3, 206

    CrossRef

  64. 64
    M.-F. Kahn, Sindrome fibromialgica, EMC - AKOS - Trattato di Medicina, 2009, 11, 4, 1

    CrossRef

  65. 65
    S. Furuta, T. Shimizu, M. Narita, K. Matsumoto, N. Kuzumaki, S. Horie, T. Suzuki, M. Narita, Subdiaphragmatic vagotomy promotes nociceptive sensitivity of deep tissue in rats, Neuroscience, 2009, 164, 3, 1252

    CrossRef

  66. 66
    Danielle Perret, Z. David Luo, Targeting voltage-gated calcium channels for neuropathic pain management, Neurotherapeutics, 2009, 6, 4, 679

    CrossRef

  67. 67
    Antonio Collado, Arantxa Conesa, Tratamiento farmacológico de la fibromialgia: hacia la neuromodulación química, Reumatología Clínica, 2009, 5, 27

    CrossRef

  68. 68
    Winfried Häuser, Kathrin Bernardy, Nurcan Üçeyler, Claudia Sommer, Treatment of fibromyalgia syndrome with gabapentin and pregabalin – A meta-analysis of randomized controlled trials, PAIN, 2009, 145, 1-2, 69

    CrossRef

  69. 69
    David A. Williams, Daniel J. Clauw, Understanding Fibromyalgia: Lessons from the Broader Pain Research Community, The Journal of Pain, 2009, 10, 8, 777

    CrossRef

  70. 70
    Sudhansu Chokroverty, Sleep Disorders Medicine, 2009,

    CrossRef

  71. 71
    Dimitri E Grigoriadis, Samuel R J Hoare, Sandra M Lechner, Deborah H Slee, John A Williams, Drugability of Extracellular Targets: Discovery of Small Molecule Drugs Targeting Allosteric, Functional, and Subunit-Selective Sites on GPCRs and Ion Channels, Neuropsychopharmacology, 2008, 34, 1, 106

    CrossRef

  72. 72
    Jacob N Ablin, Dan Buskila, Emerging therapies for fibromyalgia, Expert Opinion on Emerging Drugs, 2008, 13, 1, 53

    CrossRef

  73. 73
    Sebastian Straube, Sheena Derry, Henry J. McQuay, R. Andrew Moore, Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review, British Journal of Clinical Pharmacology, 2008, 66, 2
  74. 74
    A. Rahman, E. Reed, M. Underwood, M. E. Shipley, R. Z. Omar, Factors affecting self-efficacy and pain intensity in patients with chronic musculoskeletal pain seen in a specialist rheumatology pain clinic, Rheumatology, 2008, 47, 12, 1803

    CrossRef

  75. 75
    Dennis C. Turk, Charles J. Vierck, Elizabeth Scarbrough, Leslie J. Crofford, Nathan J. Rudin, Fibromyalgia: Combining Pharmacological and Nonpharmacological Approaches to Treating the Person, Not Just the Pain, The Journal of Pain, 2008, 9, 2, 99

    CrossRef

  76. 76
    Christine N. Huynh, Leanne M. Yanni, Laura A. Morgan, Fibromyalgia: Diagnosis and Management for the Primary Healthcare Provider, Journal of Women's Health, 2008, 17, 8, 1379

    CrossRef

  77. You have free access to this content77
    Serge Perrot, Anthony H. Dickenson, Robert M. Bennett, Fibromyalgia: Harmonizing Science with Clinical Practice Considerations, Pain Practice, 2008, 8, 3
  78. 78
    Y. Dauvilliers, B. Carlander, Fibromyalgie : exemple d’interactions entre sommeil et douleur, Douleur et Analgésie, 2008, 20, 4, 239

    CrossRef

  79. 79
    J.E Lewis, Gabapentin in the Treatment of Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial, Yearbook of Medicine, 2008, 2008, 73

    CrossRef

  80. 80
    Serena F Carville, Ernest HS Choy, Getting on with fibromyalgia, Future Rheumatology, 2008, 3, 2, 109

    CrossRef

  81. 81
    P. Arsenault, S. Potvin, Interventions pharmacologiques chez le patient fibromyalgique : par où commencer ?, Douleur et Analgésie, 2008, 20, 4, 227

    CrossRef

  82. 82
    Bernard Bannwarth, Is there a role for anticonvulsants in the management of rheumatic pain?, Joint Bone Spine, 2008, 75, 6, 633

    CrossRef

  83. 83
    Bernard Bannwarth, Les antiépileptiques ont-ils une place dans le traitement des douleurs rhumatologiques ?, Revue du Rhumatisme, 2008, 75, 12, 1205

    CrossRef

  84. 84
    Roland Staud, Donald D. Price, Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors, PAIN, 2008, 136, 3, 232

    CrossRef

  85. 85
    Carlos J Lozada, Robert W Hoffman, Management of mixed connective tissue disease, Future Rheumatology, 2008, 3, 4, 357

    CrossRef

  86. 86
    Abouch V. Krymchantowski, Juline Bryson, Richard B. Lipton, Marcelo E. Bigal, Neuromodulators for the treatment of headache disorders and fibromyalgia, Current Pain and Headache Reports, 2008, 12, 5, 333

    CrossRef

  87. 87
    Leslie J Crofford, Pain management in fibromyalgia, Current Opinion in Rheumatology, 2008, 20, 3, 246

    CrossRef

  88. 88
    Leslie J Crofford, Pain management in fibromyalgia, Current Opinion in Internal Medicine, 2008, 7, 4, 404

    CrossRef

  89. 89
    Elliot V. Hersh, Ramesh Balasubramaniam, Andres Pinto, Pharmacologic Management of Temporomandibular Disorders, Oral and Maxillofacial Surgery Clinics of North America, 2008, 20, 2, 197

    CrossRef

  90. 90
    Kim Lawson, Pharmacological treatments of fibromyalgia: Do complex conditions need complex therapies?, Drug Discovery Today, 2008, 13, 7-8, 333

    CrossRef

  91. 91
    Andrew J. Holman, Pragmatic consideration of recent randomized, placebo-controlled clinical trials for treatment of fibromyalgia, Current Pain and Headache Reports, 2008, 12, 6, 393

    CrossRef

  92. 92
    Mary E. Lynch, The Pharmacotherapy of Chronic Pain, Rheumatic Disease Clinics of North America, 2008, 34, 2, 369

    CrossRef

  93. 93
    Piercarlo Sarzi-Puttini, Dan Buskila, Mario Carrabba, Andrea Doria, Fabiola Atzeni, Treatment Strategy in Fibromyalgia Syndrome: Where Are We Now?, Seminars in Arthritis and Rheumatism, 2008, 37, 6, 353

    CrossRef

  94. 94
    Micha Abeles, Bruce M. Solitar, Michael H. Pillinger, Aryeh M. Abeles, Update on Fibromyalgia Therapy, The American Journal of Medicine, 2008, 121, 7, 555

    CrossRef

  95. 95
    Sharon B. Stanford, Lesley M. Arnold, Antiepileptic Drugs to Treat Psychiatric Disorders, 2008,

    CrossRef

  96. 96
    Kim Lawson, Are complex therapies required as pharmacological treatments of fibromyalgia?, Future Rheumatology, 2007, 2, 6, 599

    CrossRef

  97. 97
    Kelly K. Anthony, Laura E. Schanberg, Assessment and Management of Pain Syndromes and Arthritis Pain in Children and Adolescents, Rheumatic Disease Clinics of North America, 2007, 33, 3, 625

    CrossRef

  98. 98
    Ramesh Balasubramaniam, Joel M. Laudenbach, Eric T. Stoopler, Fibromyalgia: an update for oral health care providers, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2007, 104, 5, 589

    CrossRef

  99. 99
    P. Harten, Fibromyalgiesyndrom, Zeitschrift für Rheumatologie, 2007, 67, 1, 75

    CrossRef

  100. 100
    Ian Gilron, Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions, Current Opinion in Anaesthesiology, 2007, 20, 5, 456

    CrossRef

  101. 101
    Gabapentin reduces pain severity in patients with fibromyalgia, Nature Clinical Practice Neurology, 2007, 3, 8, 423

    CrossRef

  102. 102
    G. Laekeman, Gabapentine helpt bij fibromyalgie, MFM, 2007, 45, 8, 238

    CrossRef

  103. 103
    Hans-Peter Kapfhammer, Psychopharmakotherapie somatoformer Störungen und funktioneller somatischer Syndrome, Psychiatrie und Psychotherapie, 2007, 3, 4, 153

    CrossRef

  104. 104
    R Andrew Moore, Philip J Wiffen, Sheena Derry, Henry J McQuay, Gabapentin for chronic neuropathic pain and fibromyalgia in adults, The Cochrane Library,